Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis-Reference-Cited by-同舟云学术

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis

Published:2018-05-03 Issue:14 Volume:124 Page:2923-2930
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Valachis Antonios¹^ORCID,Mamounas Eleftherios P.²,Mittendorf Elizabeth A.³,Hayashi Naoki⁴^ORCID,Ishitobi Makoto⁵⁶,Natoli Clara⁷,Fitzal Florian⁸,Rubio Isabel T.⁹,Tiezzi Daniel G.¹⁰,Shin Hee-Chul¹¹,Anderson Stewart J.¹²,Hunt Kelly K.³,Matsuda Naoko⁴,Ohsumi Shozo¹³,Totomi Athina¹,Nilsson Cecilia¹⁴

Affiliation:

1. Centre for Clinical Research Sormland; Uppsala University; Uppsala Sweden

2. Comprehensive Breast Program; University of Florida Health Cancer Center-Orlando Health; Orlando Florida

3. Department of Breast Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Breast Surgery; St. Luke's International Hospital; Tokyo Japan

5. Department of Breast Surgery; Osaka International Cancer Institute; Osaka Japan

6. Department of Endocrine Surgery; Osaka International Cancer Institute; Osaka Japan

7. Department of Oral, Medical and Biotechnological Sciences; University G. D'Annunzio; Chieti-Pescara Italy

8. Department of Surgery, Breast Health Center; Medical University Vienna; Vienna Austria

9. Breast Surgical Oncology, Breast Cancer Center; University Hospital VAll d'Hebron; Barcelona Spain

10. Breast Disease Division, Department of Gynecology and Obstetrics, Ribeirao Preto Medical School; University of Sao Paulo; Sao Paulo Brazil

11. Department of Surgery; Chung-Ang University Hospital; Seoul South Korea

12. National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health; University of Pittsburgh; Pittsburgh Pennsylvania

13. Department of Breast Oncology; NHO Shikoku Cancer Center; Matsuyama Japan

14. Centre for Clinical Research; Vastmanlands County Hospital; Vasteras Sweden

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy;Hortobagyi;Cancer,1988

2. Locally advanced and inflammatory breast cancer;Chia;J Clin Oncol,2008

3. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J Natl Cancer Inst,2005

4. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer;Boughey;Ann Surg,2006

5. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Dixon in magnetic resonance breast contrast-enhanced T1 weighted high-resolution imaging for mastectomy patients at 3T: A prospective study in single center;Magnetic Resonance Imaging;2024-09

2. Recent advancements of hydrogels in immunotherapy: Breast cancer treatment;Journal of Controlled Release;2024-08

3. Omission of Breast Surgery in Exceptional Responders;Clinical Breast Cancer;2024-06

4. ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer;Journal of the American College of Radiology;2024-06

5. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study;The Lancet Regional Health - Americas;2024-04